Immunic, inc. to participate in investor conference in december

New york, nov. 26, 2024 /prnewswire/ -- immunic, inc.  (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that daniel vitt, ph.d., chief executive officer of immunic, will participate in a fireside chat on thursday, december 5, 2024, at 11:30 am et, during the piper sandler 36th annual healthcare conference, taking place december 3-5, 2024, in new york.
IMUX Ratings Summary
IMUX Quant Ranking